(CIDRAP News) Prospects for an adequate supply of seasonal influenza vaccine this year brightened today with federal approval of a new flu vaccine and a report of progress in fixing problems at Chiron's flu vaccine plant in England.
(CIDRAP News) The British biotechnology firm Acambis recently announced its launching of a quest for the Holy Grail of influenza prevention: a vaccine that would protect people from the virus for many years and perhaps even stave off future pandemic strains.
(CIDRAP News) The World Health Organization (WHO) has decided to stick with the strains of H5N1 avian influenza it chose in April 2004 for use in developing human vaccines against the virus, which many fear will trigger a flu pandemic.
(CIDRAP News) – Sanofi Pasteur has won a $97 million federal contract to develop cell-culture technology for making influenza vaccines and to design a facility to use this technology to make a pandemic flu vaccine, federal officials have announced.
(CIDRAP News) The United States will probably have enough influenza vaccine to meet the demand from people in high-risk groups next season, but it's unclear if there will be enough for everyone who wants a shot, federal health officials said today.
(CIDRAP News) Influenza vaccination coverage among people in high-risk groups this season was similar to levels in past years, signaling that the government's effort to make the most of the limited vaccine supply paid off, federal health officials reported today.
Three universities have begun recruiting volunteers for the first US clinical trial of a vaccine against H5N1 avian influenza, a key piece of the government's efforts to stave off a potential flu pandemic.